Gilotrif afatinib: Additional Phase III data

Data from a subgroup of patients with exon 19 deletion EGFR gene mutations (n=186) in the open-label, Asian Phase III LUX-Lung 6 trial in 364 patients with EGFR mutation-positive stage IIIb/IV NSCLC s...